Acrivon Therapeutics, Inc. ($ACRV)
Filing Information
| Accession Number | 0000905148-26-000212 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 15, 2026 |
| Document Date | Jan 13, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
10,000
Total Value
$17,218.00
P&L
-3.6% ($618.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jan 13, 2026 | Purchase | 10,000 | $1.72 | $17,218.00 | 75,308 | Direct | โ | View Details |